Dr. Dommasch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1340 Boylston St
Boston, MA 02215Phone+1 617-267-0900Fax+1 617-867-8646
Education & Training
- Boston University Medical CenterResidency, Dermatology, 2011 - 2014
- Pennsylvania Hospital of the University of Pennsylvania Health SystemInternship, Internal Medicine, 2010 - 2011
- Rutgers Robert Wood Johnson Medical SchoolClass of 2010
Certifications & Licensure
- MA State Medical License 2014 - 2026
- NY State Medical License 2024 - 2026
- PA State Medical License 2010 - 2011
- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- 16 citationsIncidence and Factors Associated With Acne Among Transgender Patients Receiving Masculinizing Hormone Therapy.Nick Thoreson, Jason A. Park, Chris Grasso, Jennifer Potter, Dana King
JAMA Dermatology. 2021-01-20 - 317 citationsThe risk of stroke in patients with psoriasis.Joel M. Gelfand, Erica D. Dommasch, Daniel B. Shin, Rahat S. Azfar, Shanu Kohli Kurd
The Journal of Investigative Dermatology. 2009-10-01 - 162 citationsThe risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: A systematic review and meta-analysis of randomized contr...Erica D. Dommasch, Katrina Abuabara, Daniel B. Shin, Josephine C. Nguyen, Andrea B. Troxel
Journal of the American Academy of Dermatology. 2011-06-01
Journal Articles
- Incidence and Factors Associated with Androgenetic Alopecia Among Transgender and Gender-Diverse Patients Treated with Masculinizing Hormone TherapyErica Dommasch, MD, JAMA Dermatology
- Incidence and Factors Associated with Acne Among Transgender Patients Receiving Masculinizing Hormone TherapyErica Dommasch, MD, JAMA Dermatology
- Association Between Early Severe Cardiovascular Events and Ustekinumab Treatment?Joel M Gelfand, Erica D Dommasch, JAMA Dermatology
Press Mentions
- Complications of Silicone Injections: Persistence, Stigma, and TreatmentJanuary 18th, 2023
- Acne More Likely in Transgender Patients Receiving TestosteroneMarch 17th, 2022
- Psoriasis Associated with an Increased Risk of COVID-19 in Real-World StudyApril 28th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: